Sildenafil Citrate Market – Top 10 Key Players, Emerging Trends, Region by Forecast to 2027

0

Market Research Reports, Business Advisory Services and Analytics

The growing prevalence of diabetes is expected to drive the growth of the Sildenafil Citrate Market:

HYDERABAD, TELANGANA, TELANGANA, Nov. 21, 2022 /EINPresswire.com/ — The Sildenafil Citrate market size is estimated to reach $1.91 billion by 2027, growing at a CAGR of 5.5% in during the forecast period 2022-2027. Sildenafil is a prescription drug used to treat erectile dysfunction (impotence) in men. It works by increasing blood flow to the penis. It helps men get or keep an erection. It is classified in the class of drugs recognized as phosphodiesterase type 5 (PDE 5) or phosphodiesterase 5 inhibitors. Phosphodiesterase type 5 (PDE-5) or phosphodiesterase 5 inhibitors are a new class of drugs vasoactives that have been established for the treatment of erectile dysfunction (ED). The activity technique includes active inhibition of the PDE-5 enzyme and consequent increase in cyclic guanosine monophosphate (cGMP) and effortless muscle relaxation in the penis. Sildenafil citrate (Viagra) is a potent and discriminatory PDE-5 inhibitor, which is the first drug in this class to be approved for the treatment of erectile dysfunction. Sildenafil Citrate (Viagra) is a new oral drug that limits phosphodiesterase 5 (PDE5) in the corpus cavernosum to accelerate penile erection for the treatment of male impotence. Sildenafil improves exercise capacity, WHO functional class and hemodynamics in patients with symptomatic pulmonary arterial hypertension. The growing elderly population is expected to drive Sildenafil Citrate. Booming initiatives adopted by government and non-governmental organizations to increase the awareness of erectile dysfunction including phosphodiesterase 5 inhibitors like sildenafil citrate are expected to propel the growth of the sildenafil citrate market over the course of the forecast period 2022-2027. This represents the industry outlook of Sildenafil Citrate.

Click here to browse the full summary of the report:
https://www.industryarc.com/Research/Sildenafil-Citrate-Market-Research-501922

Key points to remember
Geographically, North America Sildenafil Citrate market accounted for the highest revenue share in 2021 and it is poised to dominate the market during the period 2022-2027 owing to the increasing dominance of erectile dysfunction requiring the application of phosphodiesterase 5 inhibitors such as sildenafil citrate in North America. Region.

The growth of Sildenafil Citrate market is driven by the increasing pervasiveness of erectile dysfunction due to soaring blood pressure, diabetes and smoking, along with inactive lifestyle. However, the misuse of phosphodiesterase 5 inhibitors like sildenafil citrate by completely healthy means for recreational reasons and subsequently becomes psychologically dependent on the drug to acquire an erection and this is one of the major factors hindering the sildenafil citrate market growth.

A detailed analysis of the Sildenafil Citrate market on the strengths, weaknesses and opportunities of the key players operating in the market will be provided in the Sildenafil Citrate market report.

Want to know more about relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=501922

Segmental analysis:

Sildenafil Citrate Market Segment Analysis – By Application Type: The Sildenafil Citrate market based on application type can be further segmented into medical and non-medical uses. The medical uses segment held the largest market share in 2021. This growth is driven by the increasing application of sildenafil citrate as a phosphodiesterase 5 inhibitor in the treatment of conditions such as erectile dysfunction and erectile dysfunction. pulmonary arterial hypertension. Skyrocketing funding to trigger innovation in the various medical applications of Sildenafil Citrate is further propelling the growth of the medical uses segment. Further, the medical uses segment is expected to grow with the fastest CAGR of 6.2% during the forecast period 2022-2027 owing to the increase in application of Viagra (Sildenafil) being an inhibitor of phosphodiesterase 5 for the treatment of conditions such as altitude sickness, Raynaud’s phenomenon. and may help patients with congestive heart failure or diastolic dysfunction based on investigations.

Sildenafil Citrate Market Segment Analysis – By Application: The Sildenafil Citrate market based on application can be further segmented into erectile dysfunction, angina pectoris, pulmonary hypertension and others. The erectile dysfunction segment held the largest market share in 2021. This growth is driven by the increasing prevalence of erectile dysfunction among men globally, which has resulted in the skyrocketing application of erectile dysfunction inhibitors. phosphodiesterase 5 such as sildenafil citrate. The celebration of “National Impotence Day” and initiatives such as Men’s Health Month that raise awareness about erectile dysfunction further drive the growth of this segment. Furthermore, pulmonary hypertension segment is expected to grow with the fastest CAGR of 6.3% during the forecast period 2022-2027 owing to the wide application of sildenafil citrate in the treatment of pulmonary arterial hypertension, in which sildenafil is a phosphodiesterase 5 inhibitor which causes lung problems. arterial vasodilation and minimization of pulmonary arterial pressures based on dog investigations.

Sildenafil Citrate Market Segment Analysis – By Geography: The Sildenafil Citrate market based on geography can be further segmented into North America, Europe, Asia Pacific, South America and Rest of the World . North America (sildenafil citrate market) held the largest share with 41% of the overall market in 2021. The growth of this region is driven by the increasing pervasiveness of erectile dysfunction and the existence of a superior health care infrastructure in the region. The surge in new R&D initiatives associated with the creation of new drug molecules, the high demand for erectile dysfunction drugs like phosphodiesterase 5 inhibitors, including sildenafil citrate, and the existence of key players as Torrent Pharma Inc. in the region are propelling the growth of the Sildenafil Citrate market in the North American region.

Competitive Landscape:

Top 5 Players in Sildenafil Citrate Market are-

1. Aglowmed Pharmaceuticals Ltd.
2. Ind-Swift Limited
3.Alembic Chemical Works Co Ltd.
4.Torrent Pharmaceuticals Ltd.
5.Atlas Laboratories Pvt Ltd.

Click the Following Link to Buy Sildenafil Citrate Market Report:
https://www.industryarc.com/reports/request-quote?id=501922

Why choose IndustryARC?

IndustryARC is one of the world’s leading market research and consulting companies. It produces over 500 unique market reports every year. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your favorite market report from the website, but also get personalized support on specific reports.

Similar reports:

A. Erectile Dysfunction Drugs Market
https://www.industryarc.com/Report/17377/erectile-dysfunction-drugs-market.html

Contact us:

Mr Venkat Reddy
IndustryCRA
Email: [email protected], [email protected]
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryCRA
[email protected]
+1 614-588-8538
Visit us on social media:
Facebook
Twitter
LinkedIn

Share.

Comments are closed.